Real-time enrollment status for this metastatic colorectal cancer (crc) clinical trial
Current Status
Recruiting
Checked: November 16, 2026 at 5:30 AM UTC
| NCT Number | NCT07912593 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Colorectal Cancer (CRC) |
| Phase | PHASE1 |
| Target Enrollment | 320 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Ensem Therapeutics |
| Last Updated on CT.gov | November 12, 2026 (4 days ago) |
As of November 16, 2026: Clinical trial NCT07912593 is currently recruiting participants. This phase1 study for metastatic colorectal cancer (crc) is actively seeking new participants at 1 location across the United States. The study is sponsored by Ensem Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07912593 is actively recruiting participants as of November 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07912593 was last updated 4 days ago (November 12, 2026). HelloStudys verifies this status automatically.